Literature DB >> 15726331

Functional magnetic resonance imaging reveals similar brain activity changes in two different animal models of schizophrenia.

Céline Risterucci1, Karine Jeanneau, Stephanie Schöppenthau, Thomas Bielser, Basil Künnecke, Markus von Kienlin, Jean-Luc Moreau.   

Abstract

RATIONALE AND
OBJECTIVES: In schizophrenia research, most of the functional imaging studies have been performed in psychotic patients, but little is known about brain areas involved in the expression of psychotic-like symptoms in animal models. The objective of this study was to visualize and compare brain activity abnormalities in a neurodevelopmental and a pharmacological animal model of schizophrenia.
METHODS: Blood perfusion of specific brain areas, taken as indirect measure of brain activity, was investigated in adult rats following either neonatal ventral hippocampal lesion or acute administration of phencyclidine. Quantitative perfusion magnetic resonance imaging was performed on five frontal brain slices using the continuous arterial spin labeling technique. The mean perfusion was calculated in several brain structures, which were identified on anatomical images.
RESULTS: Lesioned animals exhibiting deficits in prepulse inhibition of the startle reflex showed a significant blood perfusion increase in the nucleus accumbens, basolateral amygdala, ventral pallidum, entorhinal-piriform cortex, orbital prefrontal cortex, and in the bed nucleus of the stria terminalis, and a decrease of perfusion in the temporal cortex. Similar effects were seen following acute phencyclidine administration in naïve animals.
CONCLUSION: Our data point out specific cortical and subcortical brain areas involved in the development of psychotic-like symptoms in two different animal models of schizophrenia. The observed brain activity abnormalities are reminiscent of classical neuroimaging findings described in schizophrenic patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15726331     DOI: 10.1007/s00213-005-2204-8

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  62 in total

1.  Fast T1 mapping on a whole-body scanner.

Authors:  R Deichmann; D Hahn; A Haase
Journal:  Magn Reson Med       Date:  1999-07       Impact factor: 4.668

Review 2.  What does fMRI tell us about neuronal activity?

Authors:  David J Heeger; David Ress
Journal:  Nat Rev Neurosci       Date:  2002-02       Impact factor: 34.870

3.  Attenuated frontal activation in schizophrenia may be task dependent.

Authors:  V A Curtis; E T Bullmore; R G Morris; M J Brammer; S C Williams; A Simmons; T Sharma; R M Murray; P K McGuire
Journal:  Schizophr Res       Date:  1999-05-04       Impact factor: 4.939

4.  FLASH imaging: rapid NMR imaging using low flip-angle pulses. 1986.

Authors:  A Haase; J Frahm; D Matthaei; W Hänicke; K-D Merboldt
Journal:  J Magn Reson       Date:  2011-12       Impact factor: 2.229

5.  Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance.

Authors:  D S Manoach; R L Gollub; E S Benson; M M Searl; D C Goff; E Halpern; C B Saper; S L Rauch
Journal:  Biol Psychiatry       Date:  2000-07-15       Impact factor: 13.382

Review 6.  Phencyclidine in the social interaction test: an animal model of schizophrenia with face and predictive validity.

Authors:  F Sams-Dodd
Journal:  Rev Neurosci       Date:  1999       Impact factor: 4.353

7.  Early amygdala damage in the rat as a model for neurodevelopmental psychopathological disorders.

Authors:  G Wolterink; L E Daenen; S Dubbeldam; M A Gerrits; R van Rijn; C G Kruse; J A Van Der Heijden; J M Van Ree
Journal:  Eur Neuropsychopharmacol       Date:  2001-02       Impact factor: 4.600

8.  Neonatal lesions of the left entorhinal cortex affect dopamine metabolism in the rat brain.

Authors:  T Uehara; Y Tanii; T Sumiyoshi; M Kurachi
Journal:  Brain Res       Date:  2000-03-31       Impact factor: 3.252

Review 9.  To model a psychiatric disorder in animals: schizophrenia as a reality test.

Authors:  B K Lipska; D R Weinberger
Journal:  Neuropsychopharmacology       Date:  2000-09       Impact factor: 7.853

Review 10.  Molecular brain imaging and the neurobiology and genetics of schizophrenia.

Authors:  A Heinz; B Romero; J Gallinat; G Juckel; D R Weinberger
Journal:  Pharmacopsychiatry       Date:  2003-11       Impact factor: 5.788

View more
  14 in total

1.  Post-pubertal disruption of medial prefrontal cortical dopamine-glutamate interactions in a developmental animal model of schizophrenia.

Authors:  Kuei-Yuan Tseng; Barbara L Lewis; Barbara K Lipska; Patricio O'Donnell
Journal:  Biol Psychiatry       Date:  2007-01-03       Impact factor: 13.382

2.  Multi-parametric neuroimaging reproducibility: a 3-T resource study.

Authors:  Bennett A Landman; Alan J Huang; Aliya Gifford; Deepti S Vikram; Issel Anne L Lim; Jonathan A D Farrell; John A Bogovic; Jun Hua; Min Chen; Samson Jarso; Seth A Smith; Suresh Joel; Susumu Mori; James J Pekar; Peter B Barker; Jerry L Prince; Peter C M van Zijl
Journal:  Neuroimage       Date:  2010-11-20       Impact factor: 6.556

3.  Neonatal exposure to phenobarbital potentiates schizophrenia-like behavioral outcomes in the rat.

Authors:  S K Bhardwaj; P A Forcelli; G Palchik; K Gale; L K Srivastava; A Kondratyev
Journal:  Neuropharmacology       Date:  2012-02-15       Impact factor: 5.250

4.  Differential Effects of Anaesthesia on the phMRI Response to Acute Ketamine Challenge.

Authors:  Duncan J Hodkinson; Carmen de Groote; Shane McKie; J F William Deakin; Steve R Williams
Journal:  Br J Med Med Res       Date:  2012-09

5.  Selective potentiation of the metabotropic glutamate receptor subtype 2 blocks phencyclidine-induced hyperlocomotion and brain activation.

Authors:  E A Hackler; N E Byun; C K Jones; J M Williams; R Baheza; S Sengupta; M D Grier; M Avison; P J Conn; J C Gore
Journal:  Neuroscience       Date:  2010-03-27       Impact factor: 3.590

6.  Cerebral perfusion differences in women currently with and recovered from anorexia nervosa.

Authors:  Min Sheng; Hanzhang Lu; Peiying Liu; Binu P Thomas; Carrie J McAdams
Journal:  Psychiatry Res       Date:  2015-02-27       Impact factor: 3.222

Review 7.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

8.  GABAergic modulation of the 40 Hz auditory steady-state response in a rat model of schizophrenia.

Authors:  Jenifer L Vohs; R Andrew Chambers; Giri P Krishnan; Brian F O'Donnell; Sarah Berg; Sandra L Morzorati
Journal:  Int J Neuropsychopharmacol       Date:  2009-07-23       Impact factor: 5.176

Review 9.  The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia.

Authors:  Kuei Y Tseng; R Andrew Chambers; Barbara K Lipska
Journal:  Behav Brain Res       Date:  2008-12-03       Impact factor: 3.332

10.  Neurochemical changes in the rat prefrontal cortex following acute phencyclidine treatment: an in vivo localized (1)H MRS study.

Authors:  Isabelle Iltis; Dee M Koski; Lynn E Eberly; Christopher D Nelson; Dinesh K Deelchand; Julien Valette; Kamil Ugurbil; Kelvin O Lim; Pierre-Gilles Henry
Journal:  NMR Biomed       Date:  2009-08       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.